Clinical Trials Directory

Trials / Conditions / Unresectable Hepatocellular Carcinoma (HCC)

Unresectable Hepatocellular Carcinoma (HCC)

8 registered clinical trials studyying Unresectable Hepatocellular Carcinoma (HCC) — 5 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingFAD Subtype-Guided Combination Therapy for Unresectable Hepatocellular Carcinoma
NCT07314372
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolPhase 2
RecruitingMDN-001 Injection for the Treatment of Unresectable Primary Hepatocellular Carcinoma.
NCT07391839
Suzhou Mednovo Yi Medical Technology Co., Ltd.Phase 1
RecruitingComparison of Response Between Combination of Transarterial Chemoembolization and Lenvatinib Therapy Versus Le
NCT07408804
Bangladesh Medical UniversityN/A
Not Yet RecruitingSBRT Combined with Camrelizumab and Apatinib for Conversion Therapy in Patients with Unresectable Hepatocellul
NCT06739317
Sun Yat-sen UniversityPhase 2 / Phase 3
RecruitingObservational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)
NCT05967143
Sirtex Medical—
TerminatedStudy on Safety and Efficacy of NMS-01940153E in Adult Patients With Unresectable Hepatocellular Carcinoma (HC
NCT05630937
Nerviano Medical SciencesPhase 1 / Phase 2
CompletedPharmacokinetic Study of E7080/Lenvatinib in Chinese Patients With Unresectable Hepatocellular Carcinoma (HCC)
NCT02953743
Eisai Co., Ltd.Phase 1
CompletedUsing Machine Learning to Identify Responders to TACE or HAIC for uHCC
NCT07368530
First Affiliated Hospital, Sun Yat-Sen University—